Bristol-Myers Squibb buy Bank of America Co.
Start price
27.12.23
/
50%
€46.75
Target price
27.12.24
€61.40
Performance (%)
-8.59%
Price
29.04.24
€41.64
Summary
This prediction is currently active. With a performance of -8.59%, the BUY prediction for Bristol-Myers Squibb by Bank_of_America_Co_ is down slightly. Dividends of €1.10 are taken into consideration when calculating the performance. This prediction currently runs until 27.12.24. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | -9.783% | -9.783% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Bank of America Co. from $72.00 to $68.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat